Rapamycin pre-treatment abrogates Tumour Necrosis Factor-\u3b1
down-regulatory effects on LXR-\u3b1 and PXR mRNA expression via
inhibition of c-Jun N-terminal kinase 1 activation in HepG2 cells
- Publication date
- 15 June 2011
- Publisher
- Universidad Cat\uf3lica de Valpara\uedso